MaRS Life Sciences Central
Accepted into MaRS Life Sciences Central.
NeuraVue is a commercialized, privacy-first AI solution for senior care, led by Responsive Behaviour Detection. It works with the video systems a facility already has and includes Unsafe Interaction Alerts, Fall Detection, and Wandering / Zone Alerts.
Programs, competitions, media and events
Accepted into MaRS Life Sciences Central.
Selected to work with Canadian long-term care operators.
Selected for the Milestone Makers Summer 2025 cohort.
Feature on NeuraVue's privacy-first monitoring platform for senior care.
Afshan Ahmad, Founder & CEO
Afshan Ahmad, Founder & CEO
Ranked #80
Top 20 Hottest Tech Companies at Collision 2023 (#19)
Global Recognition Awards™ (2023)
Accepted
Selected to work with Canadian long-term care operators
Fall 2026 Sprint
One of 15 companies selected from more than 195 applicants
Milestone Makers cohort
Qualified under the ISC AI Testing Stream (Offer T12-022675). Eligible Canadian care homes may be able to evaluate NeuraVue at no cost when program requirements are met.
Innovation project on AI-powered monitoring and real-time alerts for responsive behaviours and wandering in long-term care
Client company
Alumni
Startup program
Feature on NeuraVue's privacy-first monitoring platform for senior care
Top 20 founders (I Am Unbreakable® Global Media)
Top 10 finalist
Pitch competition participant
Resident Abuse Investigation Training: Trauma-Informed Best Practices (Toronto). NeuraVue is a sponsor and Afshan Ahmad, Founder & CEO, is speaking.
Toronto
Toronto
Privacy-first AI for senior care, built to work with the video systems a facility already has.
Updated September 2026.